112 related articles for article (PubMed ID: 26161702)
21. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
22. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
23. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
[TBL] [Abstract][Full Text] [Related]
24. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
25. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F
Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296
[TBL] [Abstract][Full Text] [Related]
26. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
27. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
[TBL] [Abstract][Full Text] [Related]
28. Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan.
Liao CH; Chien WC; Chang SY; Lin YH; Wang YC; Huang WC; Mong MC; Yang YC; Wu WT; Chen JC; Chang CH; Tsai CW; Bau DT; Chang WS
Anticancer Res; 2024 May; 44(5):1931-1938. PubMed ID: 38677743
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.
Liu Z; Xiao Y; Tang L; Jiang L; Wang Y; Zhang R; Wei Q; Lu Y
Lipids Health Dis; 2015 Nov; 14():143. PubMed ID: 26537097
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the methylene tetrahydrofolate reductase gene and their unique combinations are associated with an increased susceptibility to the renal cancers.
Ajaz S; Khaliq S; Hashmi A; Naqvi SA; Rizvi SA; Mehdi SQ
Genet Test Mol Biomarkers; 2012 May; 16(5):346-52. PubMed ID: 22106923
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma.
Abe A; Sato K; Habuchi T; Wang L; Li Z; Tsuchiya N; Ohyama C; Satoh S; Ogawa O; Kato T
Tohoku J Exp Med; 2002 Nov; 198(3):181-90. PubMed ID: 12597245
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
Wang Z; Xu Y; Zhu S
Int J Clin Exp Pathol; 2015; 8(11):15228-33. PubMed ID: 26823871
[TBL] [Abstract][Full Text] [Related]
34. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma.
Piccoli MF; Figueira M; Andreoni C; Marumo JT; Schor N; Bellini MH
Int Braz J Urol; 2007; 33(5):622-9. PubMed ID: 17980059
[TBL] [Abstract][Full Text] [Related]
36. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
[TBL] [Abstract][Full Text] [Related]
37. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.
Nakamura E; Megumi Y; Kobayashi T; Kamoto T; Ishitoya S; Terachi T; Tachibana M; Matsushiro H; Habuchi T; Kakehi Y; Ogawa O
Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893
[TBL] [Abstract][Full Text] [Related]
39. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
40. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population.
Zhu J; Ju X; Yan F; Qin C; Wang M; Ding Q; Zhang Z; Yin C
Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
